[ACL] QoQ Quarter Result on 30-Sep-2020 [#Q1]

Stock
[ACL] Australian Clinical Labs Limited
Announcement Date
29-Sep-2020
Financial Year
2021
Quarter
30-Sep-2020 [#Q1]
Profit Trend
QoQ- -35.81%
YoY- 57,174.00%
Quarter Report
ACL's Result
ACL's Financial Summary
View:
Show?
Quarter Result
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
Revenue 328,798 164,399 317,904 158,952 244,017 115,435 245,491 21.52%
PBT 5,379 2,690 81,274 40,637 35,108 15,515 -4,217 -
Tax 2,063 1,032 24,201 12,101 -9,408 5,163 -1,017 -
NP 3,300 1,650 57,073 28,537 44,455 20,678 -3,200 -
Tax Rate -38.35% -38.35% -29.78% -29.78% 26.80% -33.27% - -
Total Cost 325,498 162,749 260,831 130,416 199,562 94,758 248,691 19.67%
Ratio Analysis
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
NP Margin 1.00 1.00 17.95 17.95 18.22 17.91 -1.30 -
Per Share
30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 CAGR
EPS 0.02 0.01 0.28 0.20 0.22 0.10 -0.02 -
EPS Diluted 0.02 0.01 0.28 0.20 0.22 0.10 -0.02 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.